Lanotte P, Dubois F, Le Pogam S, Guerois C, Fimbel B, Bacq Y, Gruel Y, Goudeau A, Barin F
Laboratoire de Virologie, Centre Hospitalier Universitaire Bretonneau, Tours, France.
J Infect Dis. 1998 Aug;178(2):556-9. doi: 10.1086/517473.
Several studies have reported the spontaneous loss of hepatitis C virus (HCV) antibodies in HCV-exposed persons. However, the relationship between seroreversion and spontaneous virus clearance has yet to be precisely determined in a single homogeneous population of untreated immunocompetent patients. In this study, 32 human immunodeficiency virus-seronegative hemophiliacs who had been exposed to HCV were followed for a mean duration of 141 months; 22 remained chronic carriers (68.8%). All but 1 of the nonviremic patients (90.0%) showed partial (8 cases) or complete (2 cases) seroreversion. In contrast, all but 1 of the viremic patients (95.1%) had a stable serologic profile when analyzed by a recombinant immunoblot assay. The results indicate that any HCV antibody-positive immunocompetent patient with no detectable serum HCV RNA and normal alanine aminotransferase values and whose serial samples show a progressive decrease in the level of HCV antibodies present may be considered as having a resolved infection.
多项研究报告了丙型肝炎病毒(HCV)暴露者中HCV抗体的自发丧失情况。然而,在未经治疗的具有免疫能力的单一同质患者群体中,血清学逆转与病毒自发清除之间的关系尚未得到精确确定。在本研究中,对32名暴露于HCV的人类免疫缺陷病毒血清阴性血友病患者进行了平均141个月的随访;22人仍为慢性携带者(68.8%)。除1名非病毒血症患者外(90.0%),所有患者均出现部分(8例)或完全(2例)血清学逆转。相比之下,通过重组免疫印迹分析,除1名病毒血症患者外(95.1%),所有患者的血清学特征均稳定。结果表明,任何HCV抗体阳性、具有免疫能力、血清HCV RNA检测不到、丙氨酸转氨酶值正常且连续样本显示存在的HCV抗体水平逐渐下降的患者,可被视为感染已消除。